Annual Drug Patent Expirations for VISTOGARD
Vistogard is a drug marketed by Wellstat Therap and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has one hundred and seventy-two patent family members in twenty-one countries.
The generic ingredient in VISTOGARD is uridine triacetate. One supplier is listed for this compound. Additional details are available on the uridine triacetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com